Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose inhalational anesthetics and neurophysiological monitoring in young children under propofol-based TIVA
jRCT1041220109Completed
- Sponsor
- Komei Ito
- Start
- Dec 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of sevoflurane, desflurane, propofol and remifentanil in Spinal Cord Abnormalities and spinal deformities (2 arms), sponsored by Komei Ito. Primary endpoint: Percentage reduction of upper limb MEP amplitude. Started Dec 2022; status: completed.
02
Drugs
sevofluranedesfluranepropofolremifentanil
03
Conditions
Spinal Cord Abnormalitiesspinal deformities
Beyond the preview
Go deeper on jRCT1041220109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041220109.